Product
Pemetrexed + cisplatin
1 clinical trial
1 indication
Indication
Non Small Cell Lung CarcinomaClinical trial
A Phase III Randomized, Open-Label, Multi-Center, Global Study of MEDI4736 in Combination With Tremelimumab Therapy Versus Standard of Care Platinum-Based Chemotherapy in First-Line Treatment of Patients With Advanced or Metastatic Non Small-Cell Lung Cancer (NSCLC).Status: Active (not recruiting), Estimated PCD: 2020-09-21